General Information of the Compound
Compound ID
CP0468519
Compound Name
3-(3,4-Dihydroxy-5-nitro-benzylidene)-pentane-2,4-dione
    Show/Hide
Synonyms
Nitecapone
OR-462
    Show/Hide
Structure
Formula
C12H11NO6
Molecular Weight
265.221
Canonical SMILES
CC(=O)C(=Cc1cc(O)c(O)c(c1)[N+]([O-])=O)C(C)=O
    Show/Hide
InChI
InChI=1S/C12H11NO6/c1-6(14)9(7(2)15)3-8-4-10(13(18)19)12(17)11(16)5-8/h3-5,16-17H,1-2H3
    Show/Hide
InChIKey
UPMRZALMHVUCIN-UHFFFAOYSA-N
CAS
116313-94-1
Physicochemical Property
logP
1.5674
Rotatable Bonds
4
Heavy Atom Count
19
Polar Areas
117.74
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5464105
SID: 14774787
ChEMBL ID
CHEMBL167055
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03308, G-protein coupled receptor 35
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000007 HT-29 Homo sapiens (Human)  1
1
EC50 = 820 nM
   TI
   LI
   LO
   TS
CL000043 U2OS Homo sapiens (Human)  1
1
EC50 = 17100 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Nitecapone )
Drug Name Nitecapone
Company Orion Corp
Indication
Pain
Discontinued in Phase 2
Target(s)
Catechol-O-methyl-transferase (COMT)
Modulator